Zurueck zur Suche

Reporte zur Charge UJ482AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 3 MA 2 MI 1 OH 1

VAERS 1775060

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

mild
Staat
MI
Alter
75,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
20.09.2021
Beginn
21.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Headache

Symptomtext

EXTREMELY EXHAUSTED, HEADACHE FOR 36 HOURS, NO FEVER, COUGH, CONGESTION, LACK OF APPETITE TREATMENT: REST FOR 3 WEEKS, PLENT OF FLUID (HOT TEA)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
NONE PERFORMED
Aktuelle Erkrankungen
none
Vorgeschichte
Diabetes, arthritis
Andere Medikamente
virtgard
Allergien
none
Vorherige Impfungen
-

VAERS 957108

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

mild
Staat
MA
Alter
83,0
Geschlecht
F
Eingang
19.01.2021
Impfdatum
09.10.2020
Beginn
10.10.2020
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain

Symptomtext

Patient received high dose flu vaccine 10/9/2020. No problem day of vaccination. The next two days (10/10 and 10/11/2020) "the pain was so awful I could not lift my arm." Continues to feel light throbbing pain at site of injection. At night she has to hang arm down on side of bed and it helps. Once in a while can feel throbbing down the right arm into fingers. Patient first reported above on 1-19-2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None known
Vorgeschichte
HTN, Hyperlipidemia, GERD, Rheumatoid arthritis, hypokalemia, Vit. D Deficiency Mitral valve prolapse, hip pain
Andere Medikamente
Aspirin, Calcium, topical CBD oil, chlorthalidone, Klor-con, Losartan, Magnesium, Multivitamin, Pravastatin, Stool softener, Vitamin D
Allergien
Carafate, Lovastatin, Zoloft, Codeine
Vorherige Impfungen
-

VAERS 1839386

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

gering
Staat
OH
Alter
83,0
Geschlecht
M
Eingang
03.11.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired fluzone high dose was administered to a patient with no reported adverse event; Initial information was received on 27-Oct-2021 regarding an unsolicited valid non-serious case received from other health care professional, non-healthcare professional and physician via GMI (Global Medical Information- 00830761). This case involves a 83-years old male patient who was vaccinated with expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (Expired product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. No other concomitant vaccines were not provided. On 26-Oct-2021, the patient received 0.7ml {total} dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number UJ482AA and expiry date 31-Jun-2021 was reported) via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. Event outcome was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774860

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

gering
Staat
FL
Alter
91,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

gave a patient an expired FLUZONE HD Quadrivalent vaccine (with no reported adverse event); Initial information was received on 01-Oct-2021 regarding an unsolicited valid non-serious case from a physician via regulatory authority (under reference 00794859). This case is linked to case 2021SA327336 and 2021SA328514 (same reporter). This case involves a 91 years old female patient who received an expired dose of QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) (expired product administered). The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 01-Oct-2021, the patient received a 0.7 mL dose (total) of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (Prefilled Syringe, lot UJ482AA, expiration date: 30-Jun-2021) via intramuscular route in the upper arm for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (same day latency). It was reported "Practicing manager with provider's office is reporting they gave a patient an expired FLUZONE HD Quadrivalent vaccine. What shall we do from here? Caller repeated the above question. 2 HCP states that she saved back one box of FLUZONE HIGH DOSE because it had 1 month before it expired and the nurse accidentally pulled 3 prefilled syringes of FLUZONE HIGH DOSE from that box and gave them to 3 separate patients today 01-Oct-2021" At time of reporting, no adverse event was reported. The outcome of the event was reported as unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774859

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

gering
Staat
FL
Alter
68,0
Geschlecht
M
Eingang
09.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

nurse gave 3 separate patient's an expired FLUZONE HD Quadrivalent vaccine, with no reported adverse event; Initial information received on 01-Oct-2021 regarding an unsolicited valid non-serious case from a consumer/Non-Healthcare Professional and physician via Regulatory authority (under reference 00794848). This case is linked to case 2021SA327336 (same reporter). This case involves a 68 years old male patient who accidentally received an expired dose of QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) [expired product administered]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 01-Oct-2021, the patient received a 0.7 mL dose of suspect FLUZONE HIGH-DOSE QUADRIVALENT (Prefilled Syringe, TOTAL, lot UJ482AA, expiration date: 30-Jun-2021) via intramuscular route in the upper arm for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (same day latency). It was reported "Practicing manager with provider's office is reporting they gave a patient an expired FLUZONE HD Quadrivalent vaccine. What shall we do from here? Caller repeated the above question. 2 HCP states that she saved back one box of FLUZONE HIGH DOSE because it had 1 month before it expired and the nurse accidentally pulled 3 prefilled syringes of FLUZONE HIGH DOSE from that box and gave them to 3 separate patients today 01-Oct-2021" At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774856

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

gering
Staat
FL
Alter
77,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient received an expired dose of FLUZONE HIGH-DOSE QUADRIVALENT/no adverse event; Initial information was received on 01-Oct-2021 regarding an unsolicited valid non-serious case from a consumer or non-healthcare professional via call center via regulatory authority (reference number- 00794775). This case involves a 77 years old female patient who received an expired vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient's medical history, past medical treatment, vaccination and family history were not provided. On 01-Oct-2021, the patient received a 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ482AA and expiry date: 30-JUN-2021) via an intramuscular route in the arm nos for prophylactic vaccination. It was an actual medication error due to expired vaccine used (latency: same day). At the time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774834

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ482AA

gering
Staat
MA
Alter
59,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
20.11.2020
Beginn
20.11.2020
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

59 year old female patient received dose of FLUZONE HD QIV vaccine with no AE; 59 year old female patient received dose of FLUZONE HD QIV vaccine with no AE; 59 year old immunocompromised female patient received dose of FLUZONE HD QIV vaccine with no AE; Initial information received on 29-Sep-2021 regarding an unsolicited valid non-serious case from a Pharmacist via Medical Information (Reference number- 00791205). This case involves a 59 year old immunocompromised female patient who was vaccinated with INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (product administered to patient of inappropriate age, overdose and contraindication to vaccination). The patient's past medical history included Organ transplant with immunocompromised. The patient's past medical treatment, vaccination, concomitant medication and family history were not provided. On 20-Nov-2020, the patient received a 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ482AA and expiry date: 30-Jun-2021) via an unknown route at an unknown administration site for prophylactic vaccination. It was a case of actual medication error due to inappropriate age at vaccine administration and Overdose (latency on same day). It was also case of contraindication to vaccination (latency on same day). It was reported "Consumer is 59 Pharmacist states the consumer received the Fluzone High Dose last year on 20Nov2020 and is asking to receive it again this year since she is a transplant patient but she hasn't given it yet. Pharmacist is very busy and limited information provided also consumer received it at a different location last year". At the time of report no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Organ transplant NOS (immunocompromised)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-